Original article
Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Do Seon Songa, Jin Mo Yanga, Young Kul Jungb,
, Hyung Joon Yimb, Hee Yeon Kimc, Chang Wook Kimc, Soon Sun Kimd, Jae Youn Cheongd, Hae Lim Leee, Sung Won Leee, Jeong-Ju Yoof, Sang Gyune Kimf, Young Seok Kimf
Corresponding author
a Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea, Seoul, South Korea
b Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea
c Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
d Department of Internal Medicine, Ajou University School of Medicine, Suwon, South Korea
e Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
f Department of Internal Medicine, Bucheon Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Bucheon, South Korea
